title: Minimum effective and relapse-associated doses of risperidone and olanzapine in aggressive, intellectually disabled adults.
authors.forename: David S
authors.initials: DS
authors.lastname: Janowsky
authors.forename: Qiaoyan
authors.initials: Q
authors.lastname: Hu
authors.forename: Juste
authors.initials: J
authors.lastname: Buneviciute
authors.forename: John M
authors.initials: JM
authors.lastname: Davis
mesh_terms: D000328:Adult; D000367:Age Factors; D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D001569:Benzodiazepines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D012008:Recurrence; D018967:Risperidone / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine